Asclemed USA Inc. dba Enovachem Pharmaceuticals
Asclemed USA Inc. dba Enovachem Pharmaceuticals appears in FDA public data with 4 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0330-2021, Class III) was initiated on March 19, 2021.
Summary
- Total Recalls
- 4
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0330-2021 | Class III | Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21 | March 19, 2021 |
| D-0652-2020 | Class II | Estriol, USP, (Micronized), 0.24 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #7642 | December 9, 2019 |
| D-0651-2020 | Class II | Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #7642 | December 9, 2019 |
| D-0650-2020 | Class II | Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #7642 | December 9, 2019 |